Immune responses in pigs vaccinated with adjuvanted and non-adjuvanted a(H1N1)pdm/09 influenza vaccines used in human immunization programmes

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Lefevre, Eric A ^a   Carr, B Veronica ^a   Inman, Charlotte F ^b   Prentice, Helen ^a   Brown, Ian H ^c   Brookes, Sharon M ^c   Garcon, Fanny ^c   Hill, Michelle L ^a   Iqbal, Munir ^a   Elderfield, Ruth A ^d   Barclay, Wendy S ^d   Gubbins, Simon ^a   Bailey, Mick ^b   Charleston, Bryan ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c VETERINARY LABORATORIES AGENCY   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2 ANTIBODY; INFLUENZA VACCINE; UNCLASSIFIED DRUG; VIRUS RNA; 5 (6) CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; 5-(6)-CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; FLUORESCEIN DERIVATIVE; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; SUCCINIMIDE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIOPHAGE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; HELPER CELL; HEMAGGLUTINATION INHIBITION; IN VITRO STUDY; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; NONHUMAN; NOSE SMEAR; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; SWINE; VIRUS LOAD; ANIMAL; BLOOD; CELL LINE; CELL PROLIFERATION; COMPARATIVE STUDY; DOG; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; IMMUNOLOGY; MONONUCLEAR CELL; NONPARAMETRIC TEST; ORTHOMYXOVIRUS INFECTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION;

ORTHOMYXOVIRIDAE; PIERIS BRASSICAE; SUIDAE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL LINE; CELL PROLIFERATION; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ENZYME-LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; FLUORESCEINS; IMMUNOGLOBULIN G; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; LEUKOCYTES, MONONUCLEAR; ORTHOMYXOVIRIDAE INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; SUCCINIMIDES; SUS SCROFA; T-LYMPHOCYTE SUBSETS;

EID: 84857990072     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032400     Document Type: Article

References (33)

1. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325: 197-201.
2. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, et al. (2010) Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 362: 1708-1719.
3. Kistner O, Crowe BA, Wodal W, Kerschbaum A, Savidis-Dacho H, et al. (2010) A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models. PLoS One 5: e9349.
4. Madhun AS, Akselsen PE, Sjursen H, Pedersen G, Svindland S, et al. (2010) An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. Vaccine 29: 266-273.
5. Waddington CS, Walker WT, Oeser C, Reiner A, John T, et al. (2010) Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study. BMJ 340: c2649.
6. Hobson D, Curry RL, Beare AS, Ward-Gardner A, (1972) The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 70: 767-777.
7. de Jong JC, Palache AM, Beyer WE, Rimmelzwaan GF, Boon AC, et al. (2003) Haemagglutination-inhibiting antibody to influenza virus. Dev Biol (Basel) 115: 63-73.
8. Thomas PG, Keating R, Hulse-Post DJ, Doherty PC, (2006) Cell-mediated protection in influenza infection. Emerg Infect Dis 12: 48-54.
9. Platt R, Vincent AL, Gauger PC, Loving CL, Zanella EL, et al. (2011) Comparison of humoral and cellular immune responses to inactivated swine influenza virus vaccine in weaned pigs. Vet Immunol Immunopathol 142: 252-257.
10. Waffarn EE, Baumgarth N, (2011) Protective B cell responses to flu-no fluke! J Immunol 186: 3823-3829.
11. Haga T, Horimoto T, (2010) Animal models to study influenza virus pathogenesis and control. The open antimicrobial agents journal 2: 15-21.
12. Brown IH, (2000) The epidemiology and evolution of influenza viruses in pigs. Vet Microbiol 74: 29-46.
13. Van Poucke SG, Nicholls JM, Nauwynck HJ, Van Reeth K, (2010) Replication of avian, human and swine influenza viruses in porcine respiratory explants and association with sialic acid distribution. Virol J 7: 38.
14. van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RA, et al. (2007) Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol 171: 1215-1223.
15. Lange E, Kalthoff D, Blohm U, Teifke JP, Breithaupt A, et al. (2009) Pathogenesis and transmission of the novel swine-origin influenza virus A/H1N1 after experimental infection of pigs. J Gen Virol 90: 2119-2123.
16. Brookes SM, Nunez A, Choudhury B, Matrosovich M, Essen SC, et al. (2010) Replication, pathogenesis and transmission of pandemic (H1N1) 2009 virus in non-immune pigs. PLoS One 5: e9068.
17. Busquets N, Segales J, Cordoba L, Mussa T, Crisci E, et al. (2010) Experimental infection with H1N1 European swine influenza virus protects pigs from an infection with the 2009 pandemic H1N1 human influenza virus. Vet Res 41: 74.
18. Spackman E, Senne DA, Myers TJ, Bulaga LL, Garber LP, et al. (2002) Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol 40: 3256-3260.
19. Londt BZ, Nunez A, Banks J, Nili H, Johnson LK, et al. (2008) Pathogenesis of highly pathogenic avian influenza A/turkey/Turkey/1/2005 H5N1 in Pekin ducks (Anas platyrhynchos) infected experimentally. Avian Pathol 37: 619-627.
20. Diggle PJ, Heagerty P, Liang K-Y, Zeger SL, (2002) Analysis of longitudinal data- Second edition New York Oxford University Press Inc.
21. Ober BT, Summerfield A, Mattlinger C, Wiesmuller KH, Jung G, et al. (1998) Vaccine-induced, pseudorabies virus-specific, extrathymic CD4+CD8+ memory T-helper cells in swine. J Virol 72: 4866-4873.
22. Sinkora M, Butler JE, Holtmeier W, Sinkorova J, (2005) Lymphocyte development in fetal piglets: facts and surprises. Vet Immunol Immunopathol 108: 177-184.
23. Vijaykrishna D, Smith GJD, Pybus OG, Zhu H, Bhatt S, et al. (2011) Long-term evolution and transmission dynamics of swine influenza A virus. Nature 473: 519-523.
24. Binns RM, Licence ST, Whyte A, Wilby M, Rothkotter HJ, et al. (1995) Genetically determined CD45 variant of value in leucocyte tracing in vivo in the pig. Immunology 86: 25-33.
25. de Avila Botton S, Brum MC, Bautista E, Koster M, Weiblen R, et al. (2006) Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha. Vaccine 24: 3446-3456.
26. Tachedjian M, Boyle JS, Lew AM, Horvatic B, Scheerlinck JP, et al. (2003) Gene gun immunization in a preclinical model is enhanced by B7 targeting. Vaccine 21: 2900-2905.
27. Larsen DL, Karasin A, Zuckermann F, Olsen CW, (2000) Systemic and mucosal immune responses to H1N1 influenza virus infection in pigs. Vet Microbiol 74: 117-131.
28. Jelinek I, Leonard JN, Price GE, Brown KN, Meyer-Manlapat A, et al. (2011) TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection. J Immunol 186: 2422-2429.
29. Zaks K, Jordan M, Guth A, Sellins K, Kedl R, et al. (2006) Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes. J Immunol 176: 7335-7345.
30. Le Bon A, Tough DF, (2008) Type I interferon as a stimulus for cross-priming. Cytokine Growth Factor Rev 19: 33-40.
31. Coffman RL, Sher A, Seder RA, (2010) Vaccine adjuvants: putting innate immunity to work. Immunity 33: 492-503.
32. Kyriakis CS, Gramer MR, Barbe F, Van Doorsselaere J, Van Reeth K, (2010) Efficacy of commercial swine influenza vaccines against challenge with a recent European H1N1 field isolate. Vet Microbiol 144: 67-74.
33. Brookes SM, Garcon F, Major D, Hoschler K, Rapisarda L, et al. (2010) Abstr. P-605: Immunogenicity and protective efficacy of candidate pandemic H1N1 vaccines in the ferret model. Options for the control of influenza VII. Hong Kong SAR, China.